Abstract We have investigated the mechanism of action of the putative second messenger, cyclic ADP-ribose (cADPR), on the cardiac ryanodine-sensitive Ca2'-release channel. Current fluctuations through single Ca2'-release channels have been monitored after incorporation into planar phospholipid bilayers. We demonstrate that activation of the channel by cADPR is dependent on activating levels of cytosolic Ca2' and lifetime analysis indicates that the mechanism of action may be sensitization of the channel to Ca2+. In the absence of ATP, cADPR activates the channel in a concentration-dependent manner in the presence of 10 ,umol/L cytosolic Ca2`. However, C yclic ADP-ribose (cADPR) has been shown to cause release of Ca2' from intracellular stores in sea urchin eggs,1-3 and it has been suggested that the mechanism for the Ca2' release is activation of ryanodine-sensitive channels. As cADPR is present in cells at between 20 and 600 nmol/L4 and as there are enzymes that synthesize and degrade cADPR,24 it has been suggested that cADPR is an endogenous activator of ryanodine-sensitive Ca2+-release channels. Meszairos et a15 reported that cADPR increases the open probability (Po) of cardiac ryanodine-sensitive Ca2+-release channels incorporated into planar phospholipid bilayers. On the basis of these results, it has been claimed that cADPR can trigger the release of Ca21 from the sarcoplasmic reticulum (SR) in cardiac cells at resting (diastolic) [Ca21.5 In addition, it has become accepted dogma that cADPR directly activates either the cardiac or the brain isoform of the ryanodine receptor in sea urchin eggs and other systems.56 However, substantial evidence for these claims is lacking. To determine the mode of action (if any) of a direct effect of cADPR on the cardiac Ca2+-release channel, the channel must be isolated and incorporated into bilayers. This will eliminate the possibility of cADPR activating the channel indirectly. Meszaros et al did carry out such experiments; however, they did not consider the mechanism of the cADPR action nor the possibility that the ability of cADPR to increase Po could be altered in the presence of agents such as ATP and Mg 2+, which are thought to play an important role in controlling the Po of the Received May 31, 1994; accepted June 30, 1994. From the Department of Cardiac Medicine, National Heart and Lung Institute, University of London (UK).
ryanodine-sensitive channels. As cADPR is present in cells at between 20 and 600 nmol/L4 and as there are enzymes that synthesize and degrade cADPR,24 it has been suggested that cADPR is an endogenous activator of ryanodine-sensitive Ca2+-release channels. Meszairos et a15 reported that cADPR increases the open probability (Po) of cardiac ryanodine-sensitive Ca2+-release channels incorporated into planar phospholipid bilayers. On the basis of these results, it has been claimed that cADPR can trigger the release of Ca21 from the sarcoplasmic reticulum (SR) in cardiac cells at resting (diastolic) [Ca21.5 In addition, it has become accepted dogma that cADPR directly activates either the cardiac or the brain isoform of the ryanodine receptor in sea urchin eggs and other systems.56 However, substantial evidence for these claims is lacking. To determine the mode of action (if any) of a direct effect of cADPR on the cardiac Ca2+-release channel, the channel must be isolated and incorporated into bilayers. This will eliminate the possibility of cADPR activating the channel indirectly. Meszaros et al did carry out such experiments; however, they did not consider the mechanism of the cADPR action nor the possibility that the ability of cADPR to increase Po could be altered in the presence of agents such as ATP and Mg 2+, which are thought to play an important role in controlling the Po of the in the presence of ATP, cADPR tends to decrease open probability, indicating that cADPR may be acting at the adenine nucleotide binding site. In addition, we demonstrate that the precursor of cADPR, p-NAD+, and the breakdown product, ADP-ribose, also activate the channel. As cADPR will have to compete with much higher concentrations of f3-NAD', ADP-ribose, and ATP, we suggest that cADPR does not act as a direct endogenous trigger for the opening of the cardiac Ca2+-release channel. (Circ Res. 1994;75:596-600.)
Key Words * cyclic ADP-ribose * ryanodine receptor * Ca2+ release * cardiac excitation-contraction coupling channel in the cell.7,8 Given the structural similarity between cADPR and ATP, it is possible that they may act at, and compete for, the same activation sites on the Ca'2-release channel. Additionally, consideration must be given as to whether the precursor of cADPR, p8-NAD+, and its metabolite, ADP-ribose, may also compete with cADPR for its binding sites on the Ca2'-release channel.
Our results show that cADPR, ,B-NAD+, and ADPribose all increase Po of the Ca2'-release channel. We also show that cADPR is ineffective in the presence of ATP, suggesting that cADPR and ATP may act at the same site on the Ca2'-release channel. Because cADPR will have to compete with much higher concentrations of fl-NAD+, ADP-ribose, and ATP, it appears unlikely that cADPR can act as an endogenous regulator of SR Ca2+ release in cardiac muscle cells.
Materials and Methods
Heavy SR vesicles were isolated from sheep hearts and fused with planar phosphatidylethanolamine lipid bilayers, as previously described. 9 The vesicles fused in a fixed orientation such that the cis chamber corresponded to the cytosolic space and the trans chamber corresponded to the SR lumen. The trans chamber was held at ground, and the cis chamber was held at potentials relative to ground. After fusion, the cis chamber was perfused with 250 mmolIL HEPES For example, in the presence of 10 ,umol/L Ca'+, Po was increased from 0.026±0.004 (n=8) to 0.112±0.062 (n=6) by 10 ,umol/L cADPR, whereas at 0.1 ,umol/L cADPR, the Po was 0.027±0.015 (n=4). consistent with a sensitization of the channel to activating Ca2`by cADPR. n=5), and addition of 1 and 10 ,umol/L cADPR then has no effect on Po.
cADPR is a metabolite of I3-NAD' and is itself metabolized to ADP-ribose.2 Both compounds are structurally very similar to cADPR and might be expected to interact with the adenine nucleotide binding site. We have therefore determined the effect of these agents on the cardiac Ca2+-release channel. We find that both P-NAD+ (n=3) and ADP-ribose (n=3) are potent activators of the channel. Fig 5 shows however, cADPR appears to compete with ATP at the adenine nucleotide binding site on the channel protein.
There appears to be no distinct cADPR binding site on the cardiac SR Ca'2-release channel. Given the z-100 000-fold concentration difference in the cytosolic concentrations of cADPR and ATP, it is extremely unlikely that cADPR could exert any significant effect on channel gating in the cell. Our demonstration that in addition to cADPR, ,B-NAD+ and ADP-ribose activate the cardiac SR Ca2'-release channel lends support to this conclusion. The data and arguments in the present study are entirely compatible with a mechanism for Ca2' release from the SR of cardiac muscle involving Ca2+ as the physiological trigger.24 '25 The results of earlier studies involving cADPR-induced release of Ca2+ from intracellular stores of nonmuscle cells have been interpreted in terms of an action of this compound on a ryanodinesensitive channel. The findings of the present study suggest that this effect is not the result of direct activation of the cardiac isoform of the ryanodine receptor by cADPR.
